Logo image of GCTK

GLUCOTRACK INC (GCTK) Stock Price, Quote, News and Overview

NASDAQ:GCTK - Nasdaq - US45824Q6061 - Common Stock - Currency: USD

0.709  -0.1 (-12.47%)

After market: 0.697 -0.01 (-1.69%)

GCTK Quote, Performance and Key Statistics

GLUCOTRACK INC

NASDAQ:GCTK (2/5/2025, 8:02:12 PM)

After market: 0.697 -0.01 (-1.69%)

0.709

-0.1 (-12.47%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High99
52 Week Low0.49
Market Cap11.38M
Shares16.05M
Float11.18M
Yearly Dividend0
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO04-09 2013-04-09


GCTK short term performance overview.The bars show the price performance of GCTK in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

GCTK long term performance overview.The bars show the price performance of GCTK in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of GCTK is 0.709 USD. In the past month the price decreased by -77.77%. In the past year, price decreased by -96.92%.

GLUCOTRACK INC / GCTK Daily stock chart

GCTK Latest News, Press Releases and Analysis

News Image
14 hours ago - Chartmill

What's going on in today's session

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

News Image
a day ago - Chartmill

Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session.

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.

News Image
2 days ago - Chartmill

Tuesday's session: top gainers and losers

Stay up-to-date with the latest market trends in the middle of the day on Tuesday. Explore the top gainers and losers during today's session in our detailed report.

News Image
2 days ago - Chartmill

Traders are paying attention to the gapping stocks in Tuesday's session.

Let's delve into the US markets on Tuesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.

News Image
2 days ago - GlucoTrack, Inc.

Glucotrack, Inc. Announces Pricing of $3.0 Million Public Offering

Rutherford, NJ., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical technology company focused on the design, development, and...

News Image
2 days ago - Glucotrack, Inc.

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor

The study met its primary endpoint with no procedure or device related serious adverse events reported

GCTK Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 28.28 229.05B
ISRG INTUITIVE SURGICAL INC 80.61 210.47B
BSX BOSTON SCIENTIFIC CORP 44.48 154.71B
SYK STRYKER CORP 32.74 152.14B
MDT MEDTRONIC PLC 17.46 117.57B
BDX BECTON DICKINSON AND CO 18.62 71.07B
EW EDWARDS LIFESCIENCES CORP 27 42.52B
GEHC GE HEALTHCARE TECHNOLOGY 20.66 39.83B
IDXX IDEXX LABORATORIES INC 41.65 38.36B
RMD RESMED INC 27.44 35.61B
DXCM DEXCOM INC 52.22 34.68B
PHG KONINKLIJKE PHILIPS NVR- NY 20.62 25.78B

About GCTK

Company Profile

GCTK logo image GlucoTrack Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Rutherford, New Jersey and currently employs 6 full-time employees. The company went IPO on 2013-04-09. GlucoTrack, Inc. is focused on the design, development, and commercialization of novel technologies for people with diabetes. The firm is developing an implantable continuous glucose monitoring (CGM) for use by Type 1 diabetes patients as well as insulin-dependent Type 2 patients. The company is developing an implantable continuous blood glucose monitor (CBGM). This product is designed to have an approximately two-year implant longevity without the requirement for any wearable components. The CBGM utilizes an intravascular approach, in which the device is implanted subcutaneously and connected to a lead that is placed directly into a blood vessel. This facilitates continuous blood glucose measurements with zero lag time. The firm is also developing the Glucotrack CBGM a companion mobile application and a cloud-based solution to provide real time, data-driven personalized tools to effectively help a user manage their diabetes and assist healthcare providers with making treatment decisions.

Company Info

GLUCOTRACK INC

301 Rt 17 North, Suite 800

Rutherford NEW JERSEY US

Employees: 6

Company Website: http://www.integrity-app.com/

Investor Relations: http://www.integrity-app.com/investor-relations/

Phone: 12018427715

GCTK FAQ

What is the stock price of GCTK?

The current stock price of GCTK is 0.709 USD.


What is the symbol for GLUCOTRACK INC stock?

The exchange symbol of GLUCOTRACK INC is GCTK and it is listed on the Nasdaq exchange.


On which exchange is GCTK stock listed?

GCTK stock is listed on the Nasdaq exchange.


Is GCTK a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GCTK, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GCTK.


Does GCTK stock pay dividends?

GCTK does not pay a dividend.


What is the Price/Earnings (PE) ratio of GCTK?

GCTK does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.85).


What is the Short Interest ratio of GCTK stock?

The outstanding short interest for GCTK is 10.93% of its float.


GCTK Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GCTK Financial Highlights

Over the last trailing twelve months GCTK reported a non-GAAP Earnings per Share(EPS) of -2.85. The EPS decreased by -80.32% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -1805.69%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-89.42%
Sales Q2Q%N/A
EPS 1Y (TTM)-80.32%
Revenue 1Y (TTM)N/A

GCTK Ownership and Analysts


Ownership
Inst Owners0.55%
Ins Owners2.33%
Short Float %10.93%
Short Ratio0.02
Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A